Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.91K Hold
50
﹤0.01% 144
2026
Q1
$5.97K Hold
50
﹤0.01% 144
2025
Q4
$6.81K Hold
50
﹤0.01% 138
2025
Q3
$7.38K Hold
50
﹤0.01% 131
2025
Q2
$6.47K Hold
50
﹤0.01% 125
2025
Q1
$5.97K Hold
50
﹤0.01% 130
2024
Q4
$5.8K Hold
50
﹤0.01% 126
2024
Q3
$6.75K Hold
50
﹤0.01% 131
2024
Q2
$6.78K Hold
50
﹤0.01% 125
2024
Q1
$6.46K Hold
50
﹤0.01% 128
2023
Q4
$5.72K Hold
50
﹤0.01% 130
2023
Q3
$4.55K Sell
50
-250
-83% -$25.8K ﹤0.01% 153
2023
Q2
$33.8K Buy
+300
New +$31.7K 0.02% 72

Other funds holding XYL

Your Advocates Ltd's XYL Position: Q2 2026 in Review

Your Advocates Ltd held its Xylem (XYL) position steady in Q2 2026 at 50 shares worth $5.91K. The position accounts for ﹤0.01% of the portfolio, ranked #144.

Your Advocates Ltd first reported a position in XYL in Q2 2023 and has held it in 13 quarters since. The position peaked at $33.8K in Q2 2023. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Your Advocates Ltd held 50 shares of Xylem worth $5.91K as of Q2 2026.
  • Your Advocates Ltd left its Xylem share count unchanged in Q2 2026.
  • Xylem made up ﹤0.01% of Your Advocates Ltd's portfolio in Q2 2026, its #144 holding.
  • Your Advocates Ltd first reported a position in Xylem in Q2 2023 and has held it in 13 quarters since.
  • Your Advocates Ltd's Xylem position peaked at $33.8K in Q2 2023.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Your Advocates Ltd's 13F filing for Q2 2026, filed 5 Aug 2026.